bioMérieux, EN

Meet us at ESCMID Global April 17-21!

See how we’re elevating diagnostics for stronger Antimicrobial Stewardship.

Visit Booth A70 to experience our latest innovations: Leading Microbiology, Advancing Syndromic Molecular, Connecting Data to Decisions, Impacting One Health.

Two expert symposia: Fresh insights on STRIDES in AMR Diagnostics and real-world clinical impact of Syndromic Molecular testing.

Discover our diagnostic advances at ESCMID

News

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

bioMérieux, a world leader in in vitro diagnostics, announces the publication of a multi-country health economic analysis assessing the impact of deploying fast identification and antimicrobial susceptibility testing (ID/AST) early in the care pathway for patients with bloodstream infections at high-risk of sepsis.

Discover more

Swipe to discover more

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE® SPOTFIRE® for pharmaceutical industries, where this innovative molecular testing system is designed to transform quality control. Building on the proven success of the BIOFIRE® FILMARRAY® platform, already adopted by leading global pharmaceutical companies, BIOFIRE® SPOTFIRE® introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients.

Read the press release
Always consider sepsis in the context of infection.

Patient associations across the globe are actively engaged in promoting this critical message to both healthcare professionals and the broader public. We met with Dr Rafael Moraes from ILAS, Melissa Mead from The UK Sepsis Trust and Thomas Heymann from Sepsis Alliance to learn more about their actions.

Read the blog post
Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care

In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

Read the news

Enabling Decision-Making

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

As an antimicrobial steward

BE A GAME CHANGER

You can help sustain antibiotic efficacy for future generations with the right diagnostic tests to guide appropriate antibiotic therapy.

Discover More

In the fight against sepsis

BE A GAME CHANGER

Time is of the essence with suspected sepsis. To make rapid & accurate decisions, diagnostic is a real support. bioMérieux commits to offer a complete solution for sepsis management – from antibiotic initiation, to monitoring, to appropriate discontinuation.

Discover more

As a protector of consumer health

BE A GAME CHANGER

When you select a diagnostic partner you can trust, manufacturing safe food and beverages comes with confidence.

Discover more

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

By choosing the right partner and diagnostics solutions you can manufacture safer products, giving you confidence in the quality of your offer.

Discover more

In respiratory infections, including COVID-19

BE A GAME CHANGER

To make sure your patients don’t miss a breath, you need a partner you can count on. bioMérieux offers a comprehensive range of diagnostic tools enabling various RESPIRATORY linked infections, including primary diagnosis of SARS-CoV-2 you can rely on.

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

VITEK^® REVEAL™

The newest addition to our Sepsis Solution, VITEK^® REVEAL™ offers fast AST results to effectively and efficiently manage bloodstream infections.

VIDAS^® KUBE™

VIDAS^® KUBE™ is designed to preserve everything labs appreciate about the VIDAS^® Solution combined with advanced technology. VIDAS^® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.

BIOFIRE^® FILMARRAY^® TORCH

Syndromic infectious disease testing with BIOFIRE^® FILMARRAY^® TORCH is the fastest way to better results.

VITEK^® MS PRIME

VITEK^® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care.

BIOFIRE^® SPOTFIRE^® System

The BIOFIRE SPOTFIRE System combines BIOFIRE’s high-multiplex PCR expertise with smart design to deliver fast, reliable results.

With sample preparation and system setup completed in under 5 minutes, BIOFIRE SPOTFIRE enables syndromic testing across up to 4 modules and delivers automated results within a timeframe aligned with a typical patient visit. This efficiency may empower clinicians to make faster, more informed decisions at the Point of Care.

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat Panels

The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab, a throat swab or an anterior nasal swab, providing a flexible respiratory solution to meet the unique needs of point-of-care settings.

Respiratory Tract Infections

When a patient is suffering from respiratory symptoms, it’s challenging to know what’s causing the illness without diagnostic results. Our respiratory solutions provide fast, comprehensive, and accurate answers for optimized patient care.

GENE-UP^®

GENE-UP® delivers a Real-Time PCR technology for the detection of foodborne pathogens, spoilers and viruses; simplifying training and workflow and reducing cross contamination risk.

GENE-UP^® TYPER

Move from test results to actionable insights and make impactful decisions within 2 hours from an isolated colony with GENE UP® TYPER. This real-time PCR assay utilizes probabilistic typing of specific microorganisms to help identify the root cause of contamination and avoid future recurrence.

VIDAS KUBE close-up in a lab with technician hands preparing and handling sample

VIDAS KUBE, Food Safety and Quality, Pathogen Detection

VIDAS^® KUBE™ Automated Food Pathogens Detection

VIDAS® KUBE™ is an automated food pathogen detection system with accessible volume flexibility adding advanced automation, minimum training and higher productivity.

TEMPO^® Quality Indicator Solution

TEMPO® is a fully automated enumeration system that tests quality indicators in food products and environmental samples within your own laboratory.

ENDONEXT^™Solutions

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

3P^® ENTERPRISE

3P® ENTERPRISE delivers a full workflow automation with real‑time oversight, data integrity, and cross‑site harmonization to boost efficiency in environmental monitoring programs.

VITEK^®MS PRIME

VITEK® MS PRIME is the next level of automated MALDI-TOF Mass Spectrometry system, that allows an accurate microbial identification to the species-level.

Planting a family tree. Hands of grandfather and little boy planting young tree in the garden. Environmental awareness. Spring concept, save nature and care.

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

This dedication to public health is the thread that connects everything we do. It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and sharing. 

Discover more

Latest Articles

Always consider sepsis in the context of infection.

Modern management of chronic endocrine disorders in horses : PPID & EMS

Managing equine respiratory outbreaks: Why the syndromic approach changes everything

Accelerating the pace of innovation in cell and gene therapy – how USP <72> is set to rewrite the rules of sterility testing

Meet us at ESCMID Global April 17-21!

News

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

Always consider sepsis in the context of infection.

Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care